A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes

NCT01769404 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: LY2605541
BIOLOGICAL: Insulin Glargine

Sponsor

Eli Lilly and Company